TSH Biopharm Corporation Limited (TPEX:8432)
Taiwan
· Delayed Price · Currency is TWD 50.30
-0.10 (-0.20%)
May 12, 2025, 1:30 PM CST
TSH Biopharm Corporation Company Description
TSH Biopharm Corporation Limited develops and markets pharmaceutical products in Taiwan and Asia.
It offers products for cardiovascular, central nervous, gastrointestinal, and others. The company was founded in 1999 and is headquartered in Taipei city, Taiwan.
TSH Biopharm Corporation Limited is a subsidiary of TTY Biopharm Company Limited.
TSH Biopharm Corporation Limited
| Country | Taiwan |
| Founded | 1999 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 76 |
| CEO | Sze-Yuan Yang |
Contact Details
Address: No. 3-1, Park Street Taipei, 11503 Taiwan | |
| Phone | 886 2 2655 8525 |
| Website | tshbiopharm.com |
Stock Details
| Ticker Symbol | 8432 |
| Exchange | Taipei Exchange |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | TWD |
| ISIN Number | TW0008432006 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Sze-Yuan Yang | President |
| Jung-Liang Kao | Senior Division Director of Finance Division and Chief Financial Officer |
| Chen-Ju Kan | Senior Manager of the Accounting Department |
| Yu-Chung Wu | Senior Director of Sales |
| Chuan-Hsu Chen | Senior Director of Marketing |
| Hsin-Young Liu | Company Secretary |